Participant flow42

How many started, completed or left each group, period by period.

1 to 20 of 42

Period	Milestone	Group	Participants
Overall Study	STARTED	Arm A Exp Avelumab Starting From C1D15	16
Overall Study	STARTED	Arm A Exp Avelumab Starting From C3D1	8
Overall Study	STARTED	Arm B Exp Avelumab Starting From C1D15	16
Overall Study	STARTED	Arm B Exp Avelumab Starting From C3D1	12
Overall Study	STARTED	Arm C Escalation Avelumab Starting From C1D1	4
Overall Study	STARTED	Arm C Exp Avelumab Starting From C1D15	17
Overall Study	STARTED	Arm C Exp Avelumab Starting From C3D1	11
Overall Study	STARTED	Arm D Esc Schedule-1 Dose Level 1; XRT: Starting C1D2 to C1D11	4
Overall Study	STARTED	Arm D Esc Schedule-2 Dose Level 1; XRT: Starting Days -14 to -1	3
Overall Study	STARTED	Arm D Esc Schedule-3 Dose Level 1; XRT: Starting C1D1 to C1D3	7
Overall Study	STARTED	Arm E Esc Schedule-1 Dose Level 1; XRT: Starting C1D2 to C1D11	3
Overall Study	STARTED	Arm E Esc Schedule-2 Dose Level 1; XRT: Starting Days -14 to -1	3
Overall Study	STARTED	Arm F Esc Schedule-1 Dose Level 1; Avelumab Starting From C1D1, XRT: Starting C1D2 to C1D11	4
Overall Study	STARTED	Arm F Esc Schedule-2 Dose Level 1; Avelumab Starting From C1D15, XRT: Starting Days -14 to -1	3
Overall Study	COMPLETED	Arm A Exp Avelumab Starting From C1D15	0
Overall Study	COMPLETED	Arm A Exp Avelumab Starting From C3D1	0
Overall Study	COMPLETED	Arm B Exp Avelumab Starting From C1D15	0
Overall Study	COMPLETED	Arm B Exp Avelumab Starting From C3D1	0
Overall Study	COMPLETED	Arm C Escalation Avelumab Starting From C1D1	0
Overall Study	COMPLETED	Arm C Exp Avelumab Starting From C1D15	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03217747/flow